Qiagen Reports 13 Percent Q3 Revenue Growth on Strong Molecular Dx Sales | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen reported after markets closed yesterday that its third-quarter revenues increased 13 percent and its profit rose 81 percent, both of which exceeded guidance provided by the company in the wake of its second-quarter financial results.

Qiagen logged total revenues of $259.7 million in the third quarter of 2009 compared to $230.8 million in the same quarter last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.